Annette North's Net Worth

$6.03 Million

Estimate Recalculated Sep 17, 2024 03:13PM EST

Who is Annette North?

Annette North has an estimated net worth of $6.03 Million. This is based on reported shares across multiple companies, which include Turning Point Therapeutics, Inc., SGX PHARMACEUTICALS, INC., Kura Oncology, Inc., and AMBIT BIOSCIENCES CORP.

SEC CIK

Annette North's CIK is 0001341011

Past Insider Trading and Trends

2021 was Annette North's most active year for acquiring shares with 8 total transactions. Annette North's most active month to acquire stocks was the month of December. 2021 was Annette North's most active year for disposing of shares, totalling 25 transactions. Annette North's most active month to dispose stocks was the month of July. 2021 saw Annette North paying a total of $1,289,994.00 for 111,540 shares, this is the most they've acquired in one year. In 2021 Annette North cashed out on 145,882 shares for a total of $7,298,735.06, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Turning Point Therapeutics, Inc. No price found

EVP & General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+126.28%
15.61K
$36.30
-$24,284.70
27.98K
Feb 9
Form 4
—
0
$48.50
-$630,000.00
12.37K
Scheduled
Aug 30
Form 4
—
0
$47.02
-$900,432.92
12.37K
Scheduled
Jun 15
Form 4
+90.73%
5.88K
$17.00
$99,994.00
12.37K
May 6
Form 4
—
0
$63.40
-$1,855,939.48
6.48K
Scheduled
Mar 8
Form 4
∞
6.48K
—
—
6.48K
Feb 8
Form 4
—
0
$71.44
-$2,722,362.66
0
Scheduled
Feb 1 - Feb 2
Form 4
—
0
—
—
0
Jan 6
Form 3
—
0
—
—
0
No matching records found

SGX PHARMACEUTICALS, INC. No price found

General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Aug 20
Form 4
—
0
—
—
0
Feb 21
Form 4
—
0
—
—
0
Jan 26
Form 4
—
0
—
—
0
Mar 7
Form 3
—
0
—
—
0
No matching records found

Kura Oncology, Inc. (KURA) Snapshot price: $19.29

SVP, General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 22
Form 4
—
0
—
—
0
Jan 24
Form 4
—
0
—
—
0
Jan 23
Form 4
—
0
—
—
0
Jan 29
Form 4
—
0
—
—
0
Apr 23
Form 3
—
0
—
—
0
No matching records found

AMBIT BIOSCIENCES CORP No price found

Senior VP and General Counsel

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Nov 10
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
Jan 8
Form 3
—
0
—
—
0
No matching records found